It's time to scale that Simile.
Our ambition is to build a foundation model that can predict what anyone will do in any situation.
Research-wise, Simile in 2026 for simulation is like OpenAI in 2019 for AI assistants - signs of life, a path to scaling, yet still many open research questions.
Commercially, Simile is already a company with many amazing enterprise partners who understand the potential of simulation and will help us grow sustainably.
If simulation and this special combination of research and product is appealing to you, we’re hiring.
@simile_ai:
Today we’re announcing our Series B.
We’ve raised $200M at a $2B valuation from Greenoaks with participation from Index Ventures, Hanabi, A*, Bain Capital Ventures, CVS Health Ventures, and Definition.
Our mission is to simulate all eight billion people on earth, accurately. https://t.co/Pkumac7fI2
